annual CFF:
-$683.50M-$832.80M(-557.80%)Summary
- As of today (July 2, 2025), BIIB annual cash flow from financing activities is -$683.50 million, with the most recent change of -$832.80 million (-557.80%) on December 31, 2024.
- During the last 3 years, BIIB annual CFF has risen by +$1.40 billion (+67.24%).
- BIIB annual CFF is now -187.28% below its all-time high of $783.10 million, reached on December 31, 2015.
Performance
BIIB Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$23.00M-$30.90M(-391.14%)Summary
- As of today (July 2, 2025), BIIB quarterly cash flow from financing activities is -$23.00 million, with the most recent change of -$30.90 million (-391.14%) on March 31, 2025.
- Over the past year, BIIB quarterly CFF has increased by +$416.60 million (+94.77%).
- BIIB quarterly CFF is now -100.79% below its all-time high of $2.91 billion, reached on September 30, 2015.
Performance
BIIB quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$266.90M+$416.60M(+60.95%)Summary
- As of today (July 2, 2025), BIIB TTM cash flow from financing activities is -$266.90 million, with the most recent change of +$416.60 million (+60.95%) on March 31, 2025.
- Over the past year, BIIB TTM CFF has dropped by -$20.00 million (-8.10%).
- BIIB TTM CFF is now -110.80% below its all-time high of $2.47 billion, reached on September 30, 2015.
Performance
BIIB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIIB Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -557.8% | +94.8% | -8.1% |
| 3 y3 years | +67.2% | -39.4% | +79.8% |
| 5 y5 years | +88.3% | +99.0% | +95.8% |
BIIB Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -557.8% | +67.2% | -102.7% | +98.2% | -133.9% | +85.0% |
| 5 y | 5-year | -557.8% | +88.3% | -102.7% | +98.3% | -133.9% | +96.2% |
| alltime | all time | -187.3% | +88.3% | -100.8% | +99.2% | -110.8% | +96.4% |
BIIB Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$23.00M(-391.1%) | -$266.90M(-61.0%) |
| Dec 2024 | -$683.50M(-557.8%) | $7.90M(-219.7%) | -$683.50M(-48.9%) |
| Sep 2024 | - | -$6.60M(-97.3%) | -$1.34B(+177.3%) |
| Jun 2024 | - | -$245.20M(-44.2%) | -$482.30M(+95.3%) |
| Mar 2024 | - | -$439.60M(-32.0%) | -$246.90M(-265.4%) |
| Dec 2023 | $149.30M(-108.5%) | -$646.10M(-176.1%) | $149.30M(-81.1%) |
| Sep 2023 | - | $848.60M(-8759.2%) | $788.00M(-160.0%) |
| Jun 2023 | - | -$9.80M(-77.4%) | -$1.31B(-26.0%) |
| Mar 2023 | - | -$43.40M(+486.5%) | -$1.77B(+1.5%) |
| Dec 2022 | -$1.75B(-16.2%) | -$7.40M(-99.4%) | -$1.75B(+1.0%) |
| Sep 2022 | - | -$1.25B(+165.5%) | -$1.73B(+41.3%) |
| Jun 2022 | - | -$471.50M(+2757.6%) | -$1.22B(-7.1%) |
| Mar 2022 | - | -$16.50M(-268.4%) | -$1.32B(-36.8%) |
| Dec 2021 | -$2.09B(-60.4%) | $9.80M(-101.3%) | -$2.09B(-16.5%) |
| Sep 2021 | - | -$746.50M(+32.2%) | -$2.50B(-18.5%) |
| Jun 2021 | - | -$564.50M(-28.1%) | -$3.06B(-19.6%) |
| Mar 2021 | - | -$785.00M(+95.7%) | -$3.81B(-27.7%) |
| Dec 2020 | -$5.27B(-10.0%) | -$401.10M(-69.4%) | -$5.27B(-24.5%) |
| Sep 2020 | - | -$1.31B(-0.0%) | -$6.99B(+9.8%) |
| Jun 2020 | - | -$1.31B(-41.5%) | -$6.36B(-14.3%) |
| Mar 2020 | - | -$2.25B(+6.1%) | -$7.43B(+26.7%) |
| Dec 2019 | -$5.86B(+31.0%) | -$2.12B(+207.2%) | -$5.86B(+13.1%) |
| Sep 2019 | - | -$689.00M(-71.0%) | -$5.18B(+16.0%) |
| Jun 2019 | - | -$2.38B(+249.7%) | -$4.47B(-8.5%) |
| Mar 2019 | - | -$679.30M(-52.7%) | -$4.88B(+9.2%) |
| Dec 2018 | -$4.47B(+87.9%) | -$1.44B(-5825.1%) | -$4.47B(+19.5%) |
| Sep 2018 | - | $25.10M(-100.9%) | -$3.74B(-1.2%) |
| Jun 2018 | - | -$2.79B(+939.3%) | -$3.79B(+116.8%) |
| Mar 2018 | - | -$268.60M(-62.1%) | -$1.75B(-26.6%) |
| Dec 2017 | -$2.38B(+126.1%) | -$708.10M(+3531.3%) | -$2.38B(-0.8%) |
| Sep 2017 | - | -$19.50M(-97.4%) | -$2.40B(-10.6%) |
| Jun 2017 | - | -$751.00M(-16.7%) | -$2.68B(+37.7%) |
| Mar 2017 | - | -$901.40M(+24.1%) | -$1.95B(+85.2%) |
| Dec 2016 | -$1.05B(-234.4%) | -$726.50M(+138.0%) | -$1.05B(-58.4%) |
| Sep 2016 | - | -$305.30M(+1832.3%) | -$2.53B(-469.0%) |
| Jun 2016 | - | -$15.80M(+216.0%) | $685.10M(-1.7%) |
| Mar 2016 | - | -$5.00M(-99.8%) | $697.30M(-11.0%) |
| Dec 2015 | $783.10M(-203.6%) | -$2.20B(-175.7%) | $783.10M(-68.3%) |
| Sep 2015 | - | $2.91B(<-9900.0%) | $2.47B(-624.5%) |
| Jun 2015 | - | -$3.60M(-104.5%) | -$471.21M(-40.4%) |
| Mar 2015 | - | $80.80M(-115.7%) | -$789.98M(+4.5%) |
| Dec 2014 | -$755.90M(+5.5%) | -$513.29M(+1361.4%) | -$755.90M(+226.7%) |
| Sep 2014 | - | -$35.12M(-89.1%) | -$231.40M(-55.1%) |
| Jun 2014 | - | -$322.36M(-380.6%) | -$514.80M(+41.7%) |
| Mar 2014 | - | $114.88M(+924.8%) | -$363.20M(-49.3%) |
| Dec 2013 | -$716.50M(-18.3%) | $11.21M(-103.5%) | -$716.50M(-3.6%) |
| Sep 2013 | - | -$318.52M(+86.5%) | -$743.23M(+64.1%) |
| Jun 2013 | - | -$170.76M(-28.4%) | -$452.96M(-35.3%) |
| Mar 2013 | - | -$238.42M(+1435.8%) | -$699.64M(-20.3%) |
| Dec 2012 | -$877.48M(+174.3%) | -$15.52M(-45.0%) | -$877.48M(-12.7%) |
| Sep 2012 | - | -$28.25M(-93.2%) | -$1.00B(-6.6%) |
| Jun 2012 | - | -$417.44M(+0.3%) | -$1.08B(+69.0%) |
| Mar 2012 | - | -$416.26M(+191.5%) | -$636.29M(+98.9%) |
| Dec 2011 | -$319.86M(-82.1%) | -$142.81M(+44.1%) | -$319.86M(-754.5%) |
| Sep 2011 | - | -$99.13M(-552.5%) | $48.87M(-115.6%) |
| Jun 2011 | - | $21.91M(-121.9%) | -$313.26M(-77.0%) |
| Mar 2011 | - | -$99.83M(-144.2%) | -$1.36B(-23.7%) |
| Dec 2010 | -$1.78B(+146.5%) | $225.93M(-149.0%) | -$1.78B(-33.3%) |
| Sep 2010 | - | -$461.26M(-55.0%) | -$2.68B(+21.2%) |
| Jun 2010 | - | -$1.03B(+96.0%) | -$2.21B(+87.2%) |
| Mar 2010 | - | -$523.46M(-21.5%) | -$1.18B(+63.0%) |
| Dec 2009 | -$724.15M(-41.3%) | -$666.76M(<-9900.0%) | -$724.15M(+86.1%) |
| Sep 2009 | - | $6.38M(+102.6%) | -$389.19M(+49.3%) |
| Jun 2009 | - | $3.15M(-104.7%) | -$260.74M(-49.3%) |
| Mar 2009 | - | -$66.93M(-79.8%) | -$514.02M(-58.4%) |
| Dec 2008 | -$1.23B(+67.9%) | -$331.79M(-346.1%) | -$1.23B(+201.7%) |
| Sep 2008 | - | $134.83M(-153.9%) | -$409.18M(-78.0%) |
| Jun 2008 | - | -$250.13M(-68.2%) | -$1.86B(+20.3%) |
| Mar 2008 | - | -$787.53M(-259.5%) | -$1.55B(+110.4%) |
| Dec 2007 | -$735.22M | $493.65M(-137.5%) | -$735.22M(-36.6%) |
| Sep 2007 | - | -$1.32B(-2145.7%) | -$1.16B(+654.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $64.41M(+164.0%) | -$153.89M(-25.9%) |
| Mar 2007 | - | $24.40M(-64.4%) | -$207.66M(+39.9%) |
| Dec 2006 | -$148.41M(-84.4%) | $68.57M(-122.0%) | -$148.41M(-0.5%) |
| Sep 2006 | - | -$311.27M(-3027.1%) | -$149.10M(-182.2%) |
| Jun 2006 | - | $10.63M(-87.3%) | $181.46M(-125.1%) |
| Mar 2006 | - | $83.66M(+23.2%) | -$723.69M(-23.7%) |
| Dec 2005 | -$948.52M(+110.3%) | $67.88M(+251.9%) | -$948.52M(-1.9%) |
| Sep 2005 | - | $19.29M(-102.2%) | -$967.10M(-25.5%) |
| Jun 2005 | - | -$894.52M(+533.6%) | -$1.30B(+87.9%) |
| Mar 2005 | - | -$141.18M(-386.3%) | -$690.45M(+53.1%) |
| Dec 2004 | -$450.96M(-981.0%) | $49.31M(-115.9%) | -$450.96M(-2.2%) |
| Sep 2004 | - | -$310.92M(+8.1%) | -$461.00M(+212.9%) |
| Jun 2004 | - | -$287.65M(-392.6%) | -$147.34M(-201.5%) |
| Mar 2004 | - | $98.31M(+150.4%) | $145.22M(+183.7%) |
| Dec 2003 | $51.19M(-91.2%) | $39.26M(+1334.6%) | $51.19M(-91.3%) |
| Sep 2003 | - | $2.74M(-44.2%) | $585.67M(+0.0%) |
| Jun 2003 | - | $4.91M(+14.7%) | $585.58M(-0.2%) |
| Mar 2003 | - | $4.28M(-99.3%) | $586.99M(+0.5%) |
| Dec 2002 | $584.06M(-1104.3%) | $573.75M(>+9900.0%) | $584.06M(-9360.6%) |
| Sep 2002 | - | $2.65M(-58.0%) | -$6.31M(-85.6%) |
| Jun 2002 | - | $6.31M(+368.1%) | -$43.80M(-28.6%) |
| Mar 2002 | - | $1.35M(-108.1%) | -$61.33M(+5.5%) |
| Dec 2001 | -$58.16M(-78.4%) | -$16.62M(-52.3%) | -$58.16M(-58.1%) |
| Sep 2001 | - | -$34.84M(+210.5%) | -$138.89M(+15.5%) |
| Jun 2001 | - | -$11.22M(-347.9%) | -$120.27M(-40.6%) |
| Mar 2001 | - | $4.53M(-104.6%) | -$202.44M(-24.8%) |
| Dec 2000 | -$269.14M(+120.6%) | -$97.36M(+500.3%) | -$269.14M(-20.4%) |
| Sep 2000 | - | -$16.22M(-82.6%) | -$338.11M(+8.3%) |
| Jun 2000 | - | -$93.39M(+50.2%) | -$312.19M(+18.7%) |
| Mar 2000 | - | -$62.17M(-62.6%) | -$262.90M(+115.4%) |
| Dec 1999 | -$122.03M(+125.7%) | -$166.33M(-1814.7%) | -$122.03M(-625.5%) |
| Sep 1999 | - | $9.70M(-122.0%) | $23.22M(+182.4%) |
| Jun 1999 | - | -$44.10M(-156.0%) | $8.22M(-77.9%) |
| Mar 1999 | - | $78.70M(-473.4%) | $37.22M(-168.8%) |
| Dec 1998 | -$54.08M(-182.1%) | -$21.08M(+297.7%) | -$54.08M(-721.8%) |
| Sep 1998 | - | -$5.30M(-64.9%) | $8.70M(-37.9%) |
| Jun 1998 | - | -$15.10M(+19.8%) | $14.00M(+41.4%) |
| Mar 1998 | - | -$12.60M(-130.2%) | $9.90M(-85.0%) |
| Dec 1997 | $65.90M(+27.3%) | $41.70M(>+9900.0%) | $65.90M(+64.4%) |
| Sep 1997 | - | $0.00(-100.0%) | $40.07M(-21.8%) |
| Jun 1997 | - | -$19.20M(-144.2%) | $51.27M(-38.7%) |
| Mar 1997 | - | $43.40M(+173.4%) | $83.67M(+61.6%) |
| Dec 1996 | $51.77M(-30.0%) | $15.87M(+41.7%) | $51.77M(-16.0%) |
| Sep 1996 | - | $11.20M(-15.2%) | $61.65M(-13.0%) |
| Jun 1996 | - | $13.20M(+14.8%) | $70.85M(+18.6%) |
| Mar 1996 | - | $11.50M(-55.3%) | $59.75M(-19.2%) |
| Dec 1995 | $73.95M(+375.7%) | $25.75M(+26.2%) | $73.95M(+50.8%) |
| Sep 1995 | - | $20.40M(+871.4%) | $49.05M(+46.6%) |
| Jun 1995 | - | $2.10M(-91.8%) | $33.45M(-14.3%) |
| Mar 1995 | - | $25.70M(+2941.4%) | $39.05M(+151.2%) |
| Dec 1994 | $15.54M(+99.3%) | $845.00K(-82.4%) | $15.54M(-15.5%) |
| Sep 1994 | - | $4.80M(-37.7%) | $18.40M(+21.9%) |
| Jun 1994 | - | $7.70M(+250.0%) | $15.10M(+69.7%) |
| Mar 1994 | - | $2.20M(-40.5%) | $8.90M(+14.1%) |
| Dec 1993 | $7.80M(-22.0%) | $3.70M(+146.7%) | $7.80M(-28.4%) |
| Sep 1993 | - | $1.50M(0.0%) | $10.90M(-5.2%) |
| Jun 1993 | - | $1.50M(+36.4%) | $11.50M(+8.5%) |
| Mar 1993 | - | $1.10M(-83.8%) | $10.60M(+6.0%) |
| Dec 1992 | $10.00M(-88.4%) | $6.80M(+223.8%) | $10.00M(-88.7%) |
| Sep 1992 | - | $2.10M(+250.0%) | $88.30M(-0.5%) |
| Jun 1992 | - | $600.00K(+20.0%) | $88.70M(+1.1%) |
| Mar 1992 | - | $500.00K(-99.4%) | $87.70M(+1.4%) |
| Dec 1991 | $86.50M(-4905.6%) | $85.10M(+3304.0%) | $86.50M(>+9900.0%) |
| Sep 1991 | - | $2.50M(-725.0%) | $100.00K(-105.3%) |
| Jun 1991 | - | -$400.00K(-42.9%) | -$1.90M(+18.8%) |
| Mar 1991 | - | -$700.00K(-46.2%) | -$1.60M(-11.1%) |
| Dec 1990 | -$1.80M(-102.8%) | -$1.30M(-360.0%) | -$1.80M(+260.0%) |
| Sep 1990 | - | $500.00K(-600.0%) | -$500.00K(-50.0%) |
| Jun 1990 | - | -$100.00K(-88.9%) | -$1.00M(+11.1%) |
| Mar 1990 | - | -$900.00K | -$900.00K |
| Dec 1989 | $64.50M | - | - |
FAQ
- What is Biogen annual cash flow from financing activities?
- What is the all time high annual CFF for Biogen?
- What is Biogen annual CFF year-on-year change?
- What is Biogen quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Biogen?
- What is Biogen quarterly CFF year-on-year change?
- What is Biogen TTM cash flow from financing activities?
- What is the all time high TTM CFF for Biogen?
- What is Biogen TTM CFF year-on-year change?
What is Biogen annual cash flow from financing activities?
The current annual CFF of BIIB is -$683.50M
What is the all time high annual CFF for Biogen?
Biogen all-time high annual cash flow from financing activities is $783.10M
What is Biogen annual CFF year-on-year change?
Over the past year, BIIB annual cash flow from financing activities has changed by -$832.80M (-557.80%)
What is Biogen quarterly cash flow from financing activities?
The current quarterly CFF of BIIB is -$23.00M
What is the all time high quarterly CFF for Biogen?
Biogen all-time high quarterly cash flow from financing activities is $2.91B
What is Biogen quarterly CFF year-on-year change?
Over the past year, BIIB quarterly cash flow from financing activities has changed by +$416.60M (+94.77%)
What is Biogen TTM cash flow from financing activities?
The current TTM CFF of BIIB is -$266.90M
What is the all time high TTM CFF for Biogen?
Biogen all-time high TTM cash flow from financing activities is $2.47B
What is Biogen TTM CFF year-on-year change?
Over the past year, BIIB TTM cash flow from financing activities has changed by -$20.00M (-8.10%)